Ignite Creation Date:
2024-05-05 @ 5:11 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00404261
Status:
COMPLETED
Last Update Posted:
2012-10-18
First Post:
2006-11-27
Brief Title:
Evaluation Of Patient Satisfaction Of Metered Dose Inhaler MDI With Counter In Asthmatics And Chronic Obstructive Pulmonary Disease Patients COPD
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Study Overview
Official Title:
An Open Label Multicentre Study to Evaluate Patient Satisfaction With FluticasoneSalmeterol HFA MDI With Counter in Adult Subjects 18 Years of Age and Older With Asthma or COPD
Status:
COMPLETED
Status Verified Date:
2012-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the level of satisfaction experienced by asthma or chronic obstructive pulmonary disease COPD patients when using the FluticasoneSalmeterol HFA Metered Dose Inhaler MDI with counter as compared to using FluticasoneSalmeterol HFA MDI without counter
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None